| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Notch | 4.03e-05 | 4 | 49 | 2 | IPR008297 | |
| Domain | NODP | 4.03e-05 | 4 | 49 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 4.03e-05 | 4 | 49 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 4.03e-05 | 4 | 49 | 2 | IPR010660 | |
| Domain | NOD | 4.03e-05 | 4 | 49 | 2 | PF06816 | |
| Domain | NOD | 4.03e-05 | 4 | 49 | 2 | SM01338 | |
| Domain | NODP | 4.03e-05 | 4 | 49 | 2 | SM01339 | |
| Domain | LNR | 6.71e-05 | 5 | 49 | 2 | PS50258 | |
| Domain | Notch_dom | 1.40e-04 | 7 | 49 | 2 | IPR000800 | |
| Domain | Notch | 1.40e-04 | 7 | 49 | 2 | PF00066 | |
| Domain | NL | 1.40e-04 | 7 | 49 | 2 | SM00004 | |
| Domain | EGF_3 | 3.67e-04 | 235 | 49 | 5 | PS50026 | |
| Domain | EGF-like_dom | 4.78e-04 | 249 | 49 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 5.92e-04 | 261 | 49 | 5 | IPR013032 | |
| Domain | EGF_2 | 6.34e-04 | 265 | 49 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 7.41e-04 | 156 | 49 | 4 | IPR009030 | |
| Domain | WAP | 7.90e-04 | 16 | 49 | 2 | SM00217 | |
| Domain | WAP | 7.90e-04 | 16 | 49 | 2 | PF00095 | |
| Domain | WAP | 8.94e-04 | 17 | 49 | 2 | PS51390 | |
| Domain | - | 8.94e-04 | 17 | 49 | 2 | 4.10.75.10 | |
| Domain | Rib_L2_dom2 | 1.00e-03 | 18 | 49 | 2 | IPR014722 | |
| Domain | - | 1.00e-03 | 18 | 49 | 2 | 2.30.30.30 | |
| Domain | EGF_CA | 1.49e-03 | 86 | 49 | 3 | PF07645 | |
| Domain | WAP_dom | 1.51e-03 | 22 | 49 | 2 | IPR008197 | |
| Domain | ASX_HYDROXYL | 2.30e-03 | 100 | 49 | 3 | PS00010 | |
| Domain | hEGF | 2.44e-03 | 28 | 49 | 2 | PF12661 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.71e-03 | 106 | 49 | 3 | IPR000152 | |
| Domain | EGF | 3.32e-03 | 235 | 49 | 4 | SM00181 | |
| Domain | EGF_CA | 4.02e-03 | 122 | 49 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.21e-03 | 124 | 49 | 3 | IPR001881 | |
| Domain | EGF | 4.41e-03 | 126 | 49 | 3 | PF00008 | |
| Domain | EGF_1 | 4.44e-03 | 255 | 49 | 4 | PS00022 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.26e-05 | 5 | 26 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.26e-05 | 5 | 26 | 2 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.88e-05 | 6 | 26 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 6.83e-05 | 7 | 26 | 2 | MM14734 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.78e-04 | 11 | 26 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.13e-04 | 12 | 26 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.13e-04 | 12 | 26 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.52e-04 | 13 | 26 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.52e-04 | 13 | 26 | 2 | M47534 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.91e-04 | 18 | 26 | 2 | M614 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.08e-04 | 23 | 26 | 2 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 8.81e-04 | 24 | 26 | 2 | M11190 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.12e-03 | 27 | 26 | 2 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.20e-03 | 28 | 26 | 2 | M6177 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 1.77e-03 | 34 | 26 | 2 | M39390 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.09e-03 | 37 | 26 | 2 | M39506 | |
| Pubmed | 1.00e-06 | 371 | 50 | 7 | 15747579 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 2.03e-06 | 2 | 50 | 2 | 33665264 | |
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 2.03e-06 | 2 | 50 | 2 | 17696940 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25658374 | ||
| Pubmed | Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1. | 2.03e-06 | 2 | 50 | 2 | 20164830 | |
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 2.03e-06 | 2 | 50 | 2 | 11777956 | |
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 6.07e-06 | 3 | 50 | 2 | 25846406 | |
| Pubmed | Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. | 6.07e-06 | 3 | 50 | 2 | 15645445 | |
| Pubmed | 9.98e-06 | 985 | 50 | 9 | 12975309 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.21e-05 | 4 | 50 | 2 | 28061457 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24145721 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.21e-05 | 4 | 50 | 2 | 19404845 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 28669409 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11466531 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24151014 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11401408 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.21e-05 | 4 | 50 | 2 | 10194420 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.21e-05 | 4 | 50 | 2 | 8898100 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 11459941 | ||
| Pubmed | MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma. | 1.21e-05 | 4 | 50 | 2 | 27431799 | |
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 1.21e-05 | 4 | 50 | 2 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 1.21e-05 | 4 | 50 | 2 | 15917835 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 1.21e-05 | 4 | 50 | 2 | 17920003 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.39e-05 | 101 | 50 | 4 | 23382219 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 2.02e-05 | 5 | 50 | 2 | 21726900 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 21124806 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 23675950 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 21602525 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 11101851 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 15882997 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 20554499 | ||
| Pubmed | 2.09e-05 | 591 | 50 | 7 | 15231748 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 9111338 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 20870902 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 17822320 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 3.03e-05 | 6 | 50 | 2 | 12244553 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 19503073 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 7835890 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 18299578 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 3.03e-05 | 6 | 50 | 2 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 3.03e-05 | 6 | 50 | 2 | 22615412 | |
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 3.03e-05 | 6 | 50 | 2 | 21991352 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 4.23e-05 | 7 | 50 | 2 | 12846471 | |
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 4.23e-05 | 7 | 50 | 2 | 11518718 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 4.23e-05 | 7 | 50 | 2 | 11344305 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 5.64e-05 | 8 | 50 | 2 | 12242716 | |
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 9858718 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 11118901 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 16245338 | ||
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 12370315 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 9.05e-05 | 10 | 50 | 2 | 23665443 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 14766969 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 33915108 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.10e-04 | 11 | 50 | 2 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.10e-04 | 11 | 50 | 2 | 15499562 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 7642711 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 10878608 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.10e-04 | 11 | 50 | 2 | 9187150 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 12866128 | ||
| Pubmed | 1.16e-04 | 1049 | 50 | 8 | 27880917 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 10952889 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 15465494 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.55e-04 | 565 | 50 | 6 | 25468996 | |
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 1.56e-04 | 13 | 50 | 2 | 32929274 | |
| Pubmed | Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways. | 1.56e-04 | 13 | 50 | 2 | 20858735 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.56e-04 | 13 | 50 | 2 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.56e-04 | 13 | 50 | 2 | 20558824 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 28192800 | ||
| Pubmed | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. | 1.82e-04 | 14 | 50 | 2 | 21402699 | |
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 1.82e-04 | 14 | 50 | 2 | 34824237 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 14757642 | ||
| Pubmed | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | 2.10e-04 | 15 | 50 | 2 | 14672936 | |
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.40e-04 | 16 | 50 | 2 | 12617809 | |
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 10842072 | ||
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 17273555 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 2.40e-04 | 16 | 50 | 2 | 11739954 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.72e-04 | 17 | 50 | 2 | 15821257 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 39315665 | ||
| Pubmed | 2.94e-04 | 407 | 50 | 5 | 12693553 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 18093989 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 15689374 | ||
| Pubmed | Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. | 3.41e-04 | 19 | 50 | 2 | 14671302 | |
| Pubmed | 3.41e-04 | 19 | 50 | 2 | 16518823 | ||
| Pubmed | 4.18e-04 | 21 | 50 | 2 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 4.18e-04 | 21 | 50 | 2 | 14702043 | |
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 34998785 | ||
| Pubmed | 5.03e-04 | 23 | 50 | 2 | 14701881 | ||
| Pubmed | 5.03e-04 | 23 | 50 | 2 | 36239412 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 5.48e-04 | 24 | 50 | 2 | 21420948 | |
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 5.48e-04 | 24 | 50 | 2 | 11739537 | |
| Pubmed | 5.48e-04 | 24 | 50 | 2 | 33705438 | ||
| Pubmed | 5.95e-04 | 25 | 50 | 2 | 21786021 | ||
| Pubmed | 6.44e-04 | 26 | 50 | 2 | 25446530 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 6.44e-04 | 26 | 50 | 2 | 19369401 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.76e-03 | 473 | 50 | 4 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p14 | 1.98e-03 | 60 | 50 | 2 | chr11p14 | |
| Cytoband | 19q13.4 | 3.39e-03 | 79 | 50 | 2 | 19q13.4 | |
| Cytoband | 17q21.31 | 3.65e-03 | 82 | 50 | 2 | 17q21.31 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 5.78e-04 | 18 | 36 | 2 | 361 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.70e-03 | 718 | 36 | 6 | 28 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-06 | 177 | 50 | 5 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-06 | 181 | 50 | 5 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-06 | 187 | 50 | 5 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.97e-06 | 200 | 50 | 5 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.97e-06 | 200 | 50 | 5 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 50 | 4 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 159 | 50 | 4 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-05 | 169 | 50 | 4 | 6a2ef66d7ff69a92e8c62759482e823a07352440 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 4.43e-05 | 175 | 50 | 4 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 175 | 50 | 4 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 175 | 50 | 4 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.73e-05 | 178 | 50 | 4 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.73e-05 | 178 | 50 | 4 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-05 | 180 | 50 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 181 | 50 | 4 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 181 | 50 | 4 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 182 | 50 | 4 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-05 | 182 | 50 | 4 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.16e-05 | 182 | 50 | 4 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 50 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 50 | 4 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 183 | 50 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.50e-05 | 185 | 50 | 4 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-05 | 186 | 50 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-05 | 186 | 50 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.73e-05 | 187 | 50 | 4 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-05 | 188 | 50 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-05 | 190 | 50 | 4 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-05 | 190 | 50 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-05 | 190 | 50 | 4 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | db8dd6bbba803585bdd6a55d5c403d383f2e9acf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.35e-05 | 192 | 50 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 194 | 50 | 4 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 195 | 50 | 4 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 195 | 50 | 4 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 6.74e-05 | 195 | 50 | 4 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | (7)_MNP-(7)_Macrophage|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.88e-05 | 196 | 50 | 4 | 71ec157163278ad259c190051926bf41e4ecef46 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 197 | 50 | 4 | b9478212f14b7888e3abac02995177974ac3bd17 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-05 | 197 | 50 | 4 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-GABAergic_neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.01e-05 | 197 | 50 | 4 | 21f3ef7c3c10b4e3adde431097dfdcd513c74a95 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.29e-05 | 199 | 50 | 4 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.29e-05 | 199 | 50 | 4 | 3788f3218356aaaa10684e48d63757037f8a3a3c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.44e-05 | 200 | 50 | 4 | 26f07d271e984f375145e4c10528fba44a5811e1 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.44e-05 | 200 | 50 | 4 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.44e-05 | 200 | 50 | 4 | c3637827ceba16b0d7956c280dd2ddbc8b1ba55e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.44e-05 | 200 | 50 | 4 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.44e-05 | 200 | 50 | 4 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| Disease | Malignant neoplasm of skin | 1.01e-04 | 59 | 45 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.01e-04 | 59 | 45 | 3 | C0037286 | |
| Disease | Breast Carcinoma | 1.59e-04 | 538 | 45 | 6 | C0678222 | |
| Disease | Carcinoma, Pancreatic Ductal | 6.14e-04 | 24 | 45 | 2 | C0887833 | |
| Disease | Liver carcinoma | 1.02e-03 | 507 | 45 | 5 | C2239176 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.10e-03 | 32 | 45 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 1.12e-03 | 1074 | 45 | 7 | C0006142 | |
| Disease | Mammary Carcinoma, Human | 1.19e-03 | 525 | 45 | 5 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.19e-03 | 525 | 45 | 5 | C1257931 | |
| Disease | Mammary Neoplasms | 1.21e-03 | 527 | 45 | 5 | C1458155 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 1.46e-03 | 37 | 45 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | hip circumference | 1.74e-03 | 338 | 45 | 4 | EFO_0005093 | |
| Disease | Cutaneous Melanoma | 1.80e-03 | 41 | 45 | 2 | C0151779 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.67e-03 | 181 | 45 | 3 | DOID:684 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MCCPEVAKSCGHELL | 156 | B9A014 | |
| DPQCEKMEDGLLTCH | 556 | Q15303 | |
| ADMDLHCDCAAETPA | 41 | Q8N7J2 | |
| AHLCRAQMCAPKSAE | 86 | Q8IYW2 | |
| QELMSCLDLKECGHA | 91 | Q9H2A7 | |
| EELCLHIMKCNLGSP | 1016 | Q7Z478 | |
| TDQPKICDGHGCEAM | 2766 | Q01484 | |
| AADLPEHQGNLKMCC | 461 | Q5VWQ8 | |
| CALNKPGCEHECVNM | 406 | O00339 | |
| DNGITPTKNLCHMDC | 86 | Q96QH8 | |
| DMHKDSICQCPALVG | 96 | Q9ULD2 | |
| DGMNILCDALLHPNC | 761 | P59045 | |
| SHLGLKPFACDACGM | 556 | Q14526 | |
| SDNCLKMLCEVAIPH | 741 | Q8NI77 | |
| ACCPAKMILDNHDIS | 546 | Q5HYC2 | |
| PMGKTGLLCHLDDAC | 341 | Q9UM47 | |
| KMQEDPASKCHCSAN | 36 | P15248 | |
| CGDLNMHPEDLGCCL | 176 | O60906 | |
| HCKEVNCSSPADMDG | 906 | P20023 | |
| AACPQAHFMLKGDDD | 206 | Q9C0J1 | |
| PLDNSMGDSDCLHKH | 421 | P21554 | |
| NLPHTDFTLCKCMID | 76 | Q9UBQ5 | |
| ACDSQDEGRPCSMKH | 281 | Q86TE4 | |
| RLMPNSQKDCHCLGD | 781 | Q69YH5 | |
| ALRMAPDHEKACIAC | 236 | Q99615 | |
| PLGCDDDLPSLCCMH | 2076 | Q8IWT3 | |
| APIEKNEGCLHMTCA | 2241 | Q8IWT3 | |
| CPKDMAPSHCAEHKD | 86 | O95479 | |
| QCGPSSAVCMHDLKT | 76 | P11717 | |
| NGSKSPDHCEEPMSC | 276 | Q9Y4G2 | |
| HMNPCLEGEDCKVLP | 106 | Q96LR4 | |
| DTQLKPCGHSDLCMD | 536 | Q96DX4 | |
| ECPDQAGHRKNMCAL | 266 | Q7RTX9 | |
| LENSMCCKPLHCGDF | 866 | Q9ULL8 | |
| LGAAKMLLDSEQHPC | 211 | Q96C36 | |
| LQPDFCLNDGKCDIM | 1056 | Q9BZV3 | |
| HLEDMCLSQPCHGDA | 391 | Q99466 | |
| MAKNPPENCEDCHIL | 1 | Q9H2S6 | |
| GGKHEPNMQLLCDEC | 351 | Q96PU4 | |
| PMNHLCHKDSDCSGK | 91 | Q8TCV5 | |
| CDMCGPFLKDILHLA | 116 | P52740 | |
| CPIMHCNKEFDNGHL | 171 | Q9Y4E5 | |
| ADLPHKCSDCLMRFG | 456 | Q9UID6 | |
| LSPGALDKCMQDHDC | 621 | Q6SZW1 | |
| CEILKTMCPDQCSGH | 641 | Q9P273 | |
| CHPSLERKDDNMGCA | 1031 | Q5VWN6 | |
| ESGLFQKAHPCEMCD | 81 | Q9HCX3 | |
| QKAHPCEMCDPLLKD | 86 | Q9HCX3 | |
| GHMDHLLPGCEDKNC | 271 | Q8TB96 | |
| SDCDPDGPLMCHTTK | 466 | Q15029 | |
| MKEESAAQLGCCHRP | 1 | Q8IZ20 | |
| AKEIAMACSAALCPH | 1451 | Q7Z3T8 | |
| PKEATCDHFMCLQQG | 106 | Q8TEU8 |